Gloria López

Dr. Gloria López

University of the Republic, Montevideo, Uruguay
+1
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
NRNatalia Rios
Natalia Rios
LPLucía Piacenza
Lucía Piacenza
MTMadia Trujillo
Madia Trujillo
AMAlejandra Martínez
Alejandra Martínez
VDVerónica Demicheli
Verónica Demicheli
RRRafael Radi
Rafael Radi

12 December 2008 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
AFAna M. Ferreira
Ana M. Ferreira
MFMariana I. Ferrari
Mariana I. Ferrari
Andrés TrostchanskyAndrés Trostchansky
Andrés Trostchansky
CBCarlos Batthyany
Carlos Batthyany
JSJosé M. Souza
José M. Souza
Homero RubboHomero Rubbo
Homero Rubbo
Nitroalkene derivatives of fatty acids act as adaptive, anti-inflammatory signalling mediators, based on their high-affinity PPARγ (peroxisome-proliferator-activated receptor γ) ligand activity and electrophilic reactivity with proteins, including transcription factors. Although free or esterified lipid nitroalkene derivatives have been detected in human plasma and urine, their generation by inflammatory stimuli has not been reported. In the present study, we show increased nitration of cholesteryl-linoleate by activated murine J774.1 macrophages, yielding the mononitrated nitroalkene CLNO2 (cholesteryl-nitrolinoleate). CLNO2 levels were found to increase ∼20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-γ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the •NO (nitric oxide) inhibitor L-NAME (NG-nitro-L-arginine methyl ester). Macrophage (J774.1 and bone-marrow-derived cells) inflammatory responses were suppressed when activated in the presence of CLNO2 or LNO2 (nitrolinoleate). This included: (i) inhibition of NOS2 expression and cytokine secretion through PPARγ and •NO-independent mechanisms; (ii) induction of haem oxygenase-1 expression; and (iii) inhibition of NF-κB (nuclear factor κB) activation. Overall, these results suggest that lipid nitration occurs as part of the response of macrophages to inflammatory stimuli involving NOS2 induction and that these by-products of nitro-oxidative reactions may act as novel adaptive down-regulators of inflammatory responses.

1 December 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Guzmán AlvarezGuzmán Alvarez
Guzmán Alvarez
BABeatriz Aguirre-López
Beatriz Aguirre-López
JVJavier Varela
Javier Varela
MCMauricio Cabrera
Mauricio Cabrera
AMAlicia Merlino
Alicia Merlino
AGArmando Gómez-Puyou
Armando Gómez-Puyou

20 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FRFabiana Ross
Fabiana Ross
PHPaola Hernández
Paola Hernández
WPWilliams Porcal
Williams Porcal
GLGloria López
Gloria López
HCHugo Cerecetto
Hugo Cerecetto
GSGustavo Salinas
Gustavo Salinas
Parasitic flatworms are responsible for serious infectious diseases that affect humans as well as livestock animals in vast regions of the world. Yet, the drug armamentarium available for treatment of these infections is limited: praziquantel is the single drug currently available for 200 million people infected with Schistosoma spp. and there is justified concern about emergence of drug resistance. Thioredoxin glutathione reductase (TGR) is an essential core enzyme for redox homeostasis in flatworm parasites. In this work, we searched for flatworm TGR inhibitors testing compounds belonging to various families known to inhibit thioredoxin reductase or TGR and also additional electrophilic compounds. Several furoxans and one thiadiazole potently inhibited TGRs from both classes of parasitic flatworms: cestoda (tapeworms) and trematoda (flukes), while several benzofuroxans and a quinoxaline moderately inhibited TGRs. Remarkably, five active compounds from diverse families possessed a phenylsulfonyl group, strongly suggesting that this moiety is a new pharmacophore. The most active inhibitors were further characterized and displayed slow and nearly irreversible binding to TGR. These compounds efficiently killed Echinococcus granulosus larval worms and Fasciola hepatica newly excysted juveniles in vitro at a 20 µM concentration. Our results support the concept that the redox metabolism of flatworm parasites is precarious and particularly susceptible to destabilization, show that furoxans can be used to target both flukes and tapeworms, and identified phenylsulfonyl as a new drug-hit moiety for both classes of flatworm parasites.

1 February 2021 in Redox Biology
Verified
Journal Article
Open access
RDRosina Dapueto
Rosina Dapueto
JRJorge Rodriguez-Duarte
Jorge Rodriguez-Duarte
GGGermán Galliussi
Germán Galliussi
AKAndrés Kamaid
Andrés Kamaid
MBMariana Bresque
Mariana Bresque
CECarlos Escande
Carlos Escande
Chronic metabolic diseases, like obesity, type II diabetes and atherosclerosis often involve a low-grade and sterile systemic inflammatory state, in which activation of the pro-inflammatory transcription factor NF-kB and the NLRP3 inflammasome play a major role. It is well established that genetic inhibition of the NLRP3 inflammasome ameliorates acute and chronic inflammation. Indeed, accumulating experimental evidences in murine models and also in humans suggest that inhibition of the NLRP3 inflammasome might be a suitable approach to tackle the deleterious effects of chronic metabolic diseases. In this work, we explored our previously synthesized nitroalkene-Trolox™ derivative named NATx0, as a non-conventional anti-inflammatory strategy to treat chronic inflammatory diseases, such as obesity-induced glucose intolerance. We found that NATx0 inhibited NF-kB nuclear translocation and pro-inflammatory gene expression in macrophages in vitro. In addition, treatment with NATx0 prevented NLRP3 inflammasome activation after LPS/ATP stimulation in macrophages in vitro. When tested acutely in vivo, NATx0 inhibited neutrophil recruitment in zebrafish larvae, and also diminished IL-1β production after LPS challenge in mice. Finally, when NATx0 was administered chronically to diet-induced obese mice, it decreased muscle tissue inflammation and glucose intolerance, leading to improved glucose homeostasis. In conclusion, we propose that this novel nitroalkene-Trolox derivative is a suitable tool to tackle acute and chronic inflammation in vitro and in vivo mainly due to inhibition of NF-kB/NLRP3 activation.

1 October 2005 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Open access
GLGloria López
Gloria López
CBCarlos Batthyány
Carlos Batthyány
FBFabiana Blanco
Fabiana Blanco
HBHoracio Botti
Horacio Botti
Andrés TrostchanskyAndrés Trostchansky
Andrés Trostchansky
Homero RubboHomero Rubbo
Homero Rubbo
Synthesis and biological characterization of a series of alpha-tocopherol analogs with NO-releasing capacity are reported. The selected NO-donor moieties were nitrooxy and furoxan. All products were tested for their in vitro NO-releasing capacities, vasodilating properties, and antiplatelet activity. They were also capable of preventing LDL oxidation.